{"id":51442,"date":"2023-09-20T09:21:39","date_gmt":"2023-09-20T09:21:39","guid":{"rendered":"https:\/\/medsname.com\/arkamin\/"},"modified":"2026-09-12T04:33:28","modified_gmt":"2026-09-12T04:33:28","slug":"arkamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/sv\/product\/arkamin\/","title":{"rendered":"Arkamin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin: 0 0 8px 0; font-size: 16px; font-weight: bold;\">\u26a1 Quick Answer \u2014 What is Arkamin?<\/h3>\n<p style=\"margin: 0;\"><strong>Arkamin<\/strong> \u00e4r en <strong>100 mcg Clonidin tablett<\/strong> from Torrent Pharma \u2014 a <strong>centralt verkande alfa-2 adrenerg agonist (imidazolin) som minskar den sympatiska utfl\u00f6det<\/strong>, verkar p\u00e5 <strong>presynaptiska alfa-2 adrenerga receptorer (och imidazolin-1-receptorer) i rostrala ventrolaterala medulla<\/strong>. Clonidin introducerades av Boehringer Ingelheim 1966 som <strong>Catapres<\/strong>. Ursprungligen syntetiserad som ett n\u00e4sspray, en slumpm\u00e4ssig observation av kraftig hypotoni hos en f\u00f6rs\u00f6ksperson ledde till dess omvandling till ett antihypertensivt l\u00e4kemedel. Modern anv\u00e4ndning omfattar hypertoni (fj\u00e4rdehandsval och hypertensiv akutbehandling), <strong>ADHD<\/strong> (FDA-godk\u00e4nd i USA som Kapvay ER), <strong>opioid- och nikotinabstinens<\/strong>, menopausala vasomotoriska symptom, Tourettes syndrom, sm\u00e4rtbehandling som till\u00e4gg (intratekal), och anestesif\u00f6rberedelse. Halveringstid 12-16 timmar (oralt); 20-24 timmar (transdermal pl\u00e5ster); b\u00f6rjar verka efter 30-60 minuter (oralt); toppkoncentration i plasma 1-3 timmar; antihypertensiv effekt 2-4 timmar; varaktighet 8-12 timmar. Prim\u00e4ra indikationer: <strong>resistent eller fj\u00e4rdehands hypertoni, hypertensiv akutsituation (oralt\/sublingualt), ADHD, opioid\/nikotinabstinens, menopausala rodnader, sm\u00e4rtbehandling och anestesi som till\u00e4gg<\/strong>. Vanlig dosering: <strong>Kronisk hypertoni:<\/strong> 100 mcg (0,1 mg) tv\u00e5 eller tre g\u00e5nger dagligen, titrering till en vanlig maxdos p\u00e5 800 mcg\/dag. <strong>Inte en f\u00f6rstahandsbehandling vid hypertoni<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Hypertensiv akutsituation (oralt):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents. <strong>Avbryt aldrig Arkamin abrupt<\/strong> \u2014 rebound hypertension is severe and potentially life-threatening. For most hypertensive patients, modern treatment starts with an ACE inhibitor\/ARB, a calcium-channel blocker, a thiazide, and spironolactone before reaching for an alpha-blocker or centrally-acting agent.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Vad du f\u00e5r med MedsBase:<\/strong> WHO-GMP-certifierad tillverkare \u00b7 Diskret f\u00f6rpackning \u00b7 V\u00e4rldsvid leverans \u00b7 1 400+ verifierade <a href=\"https:\/\/medsbase.com\/sv\/reviews\/\">kundrecensioner<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r <a href=\"https:\/\/medsbase.com\/sv\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n<h3>Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n<p>V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rlden \u00f6ver i diskret, enkel f\u00f6rpackning \u2014 inget l\u00e4kemedelsnamn p\u00e5 paketets utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdragsbeskrivningar inkluderar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">Vad \u00e4r Arkamin?<\/h2>\n<p>Arkamin \u00e4r ett oralt 100 mcg Clonidin-tablett fr\u00e5n Torrent Pharma, levereras i 30-90 tabletter. Clonidin introducerades av Boehringer Ingelheim 1966 som <strong>Catapres<\/strong>. Ursprungligen syntetiserad som ett n\u00e4sspray, en slumpm\u00e4ssig observation av kraftig hypotoni hos en f\u00f6rs\u00f6ksperson ledde till dess omvandling till ett antihypertensivt l\u00e4kemedel. Modern anv\u00e4ndning omfattar hypertoni (fj\u00e4rdehandsval och hypertensiv akutbehandling), <strong>ADHD<\/strong> (FDA-godk\u00e4nd i USA som Kapvay ER), <strong>opioid- och nikotinabstinens<\/strong>, menopausala vasomotoriska symptom, Tourettes syndrom, sm\u00e4rtlindring (intratekal), och anestesif\u00f6rberedelse.<\/p>\n<h2 class=\"wp-block-heading\">Hur Klonidin Fungerar<\/h2>\n<p>Klonidin verkar p\u00e5 <strong>presynaptiska alfa-2 adrenerga receptorer (och imidazolin-1-receptorer) i rostrala ventrolaterala medulla<\/strong>. De nedstr\u00f6ms effekterna:<\/p>\n<ul>\n<li><strong>Minskad central sympatisk utfl\u00f6de<\/strong> \u2014 activation of pre-synaptic alpha-2 receptors in the rostral ventrolateral medulla suppresses descending sympathetic tone to the peripheral vasculature and heart<\/li>\n<li><strong>Minskad plasmanoradrenalin<\/strong> \u2014 circulating catecholamines fall 30-50% within hours; heart rate drops 5-15 bpm; BP drops 10-30 mmHg<\/li>\n<li><strong>Imidazolin-1-receptoraktivitet<\/strong> \u2014 an additional sympathetic-suppressing mechanism unique to imidazoline agonists (clonidine, moxonidine); may contribute to better metabolic tolerability than older centrally-acting drugs<\/li>\n<li><strong>Spinal och supraspinal sm\u00e4rtlindrande verkan<\/strong> \u2014 blocks pain signal relay in the dorsal horn; basis for intrathecal clonidine in chronic pain and for anaesthetic-adjunct use<\/li>\n<li><strong>H\u00e4mning av noradrenerga abstinenssymptom<\/strong> \u2014 reduces sweating, tremor, tachycardia, and hypertension during opioid, nicotine, and alcohol withdrawal<\/li>\n<li><strong>F\u00f6rb\u00e4ttrad prefrontalkortikal ton<\/strong> \u2014 proposed mechanism for ADHD benefit (enhances top-down inhibitory control)<\/li>\n<li><strong>Central anti-termoregulatorisk verkan<\/strong> \u2014 basis for menopausal hot-flush benefit<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Godk\u00e4nda och evidensbaserade anv\u00e4ndningsomr\u00e5den<\/h2>\n<ul>\n<li><strong>Resistent eller fj\u00e4rdehands hypertoni, hypertensiv akutsituation (oral\/sublingual), ADHD, opiat\/nicotinabstinens, menopausala flushes, sm\u00e4rtlindring och anestetiskt st\u00f6d<\/strong><\/li>\n<li><strong>Resistent hypertoni<\/strong> (fj\u00e4rde\/femtehands)<\/li>\n<li><strong>Hypertensiv akutsituation<\/strong> (oral 100-200 mcg loading, then 100 mcg hourly) \u2014 not for emergency with end-organ damage<\/li>\n<li><strong>ADHD<\/strong> (FDA-godk\u00e4nd som f\u00f6rl\u00e5ngsaktad Kapvay; standard IR-former anv\u00e4nds off-label globalt)<\/li>\n<li><strong>Opioid- och nikotinabstinens<\/strong> \u2014 autonomic symptom relief<\/li>\n<li><strong>Menopausala vasomotoriska symptom (v\u00e5ningar)<\/strong> \u2014 non-hormonal option<\/li>\n<li><strong>Tourettes syndrom<\/strong> och ticsyndrom<\/li>\n<li><strong>Kronisk sm\u00e4rta<\/strong> \u2014 intrathecal clonidine for neuropathic or cancer pain<\/li>\n<li><strong>Anestesif\u00f6rberedelse och perioperativ frysning<\/strong><\/li>\n<\/ul>\n<p><strong>Viktiga kliniska studier:<\/strong> <strong>VA:s samarbetsstudie om hypertoni (1967-1970)<\/strong> \u2014 clonidine established as effective monotherapy in the era before ACEi, ARB, and CCB classes. <strong>ALLHAT-subgruppsanalyser<\/strong> \u2014 clonidine-based regimens generally reduced BP equivalently to first-line classes but with worse tolerability. <strong>Connor et al.s pediatriska ADHD-studier<\/strong> \u2014 clonidine IR effective for hyperarousal and sleep disturbance in ADHD, though psychostimulants remain first-line. <strong>Gold et al. (1978)<\/strong> \u2014 landmark demonstration of clonidine for opiate withdrawal \u2014 abolished autonomic symptoms (sweating, piloerection, tachycardia) without cross-dependence.<\/p>\n<h2 class=\"wp-block-heading\">Arkamin Dosering<\/h2>\n<p><strong>Prim\u00e4r dos:<\/strong> <strong>Kronisk hypertoni:<\/strong> 100 mcg (0,1 mg) tv\u00e5 eller tre g\u00e5nger dagligen, titrering till en vanlig maxdos p\u00e5 800 mcg\/dag. <strong>Inte en f\u00f6rstahandsbehandling vid hypertoni<\/strong> \u2014 reserve for fourth\/fifth-line after ACEi\/ARB, CCB, thiazide, and spironolactone. <strong>Hypertensiv akutsituation (oralt):<\/strong> 100-200 mcg loading dose, then 100 mcg every hour up to 600 mcg; lowers BP by 10-20% within 1-2 hours. Not for hypertensive emergency (end-organ damage) \u2014 use IV agents.<\/p>\n<p><strong>Andra indikationer:<\/strong> <strong>ADHD (barn och ungdomar):<\/strong> 50-100 mcg vid l\u00e4ggdags initialt, titrering till 100-400 mcg\/dag i delade doser. F\u00f6rl\u00e5ngsamma fris\u00e4ttningsformuleringar (Kapvay) f\u00f6redras i USA. <strong>Opioidabstinens (lindring av autonoma symptom):<\/strong> 100-300 mcg tre eller fyra g\u00e5nger dagligen, med successiv minskning n\u00e4r abstinensen avtar. <strong>Menopausala v\u00e5ta anfall:<\/strong> 50-75 mcg tv\u00e5 g\u00e5nger dagligen. <strong>Tourettes syndrom:<\/strong> 25-100 mcg tv\u00e5 eller tre g\u00e5nger dagligen. <strong>R\u00f6kavv\u00e4njning:<\/strong> 100-300 mcg\/dag (oralt eller transdermalt). <strong>Anestesif\u00f6rberedelse:<\/strong> 200-400 mcg oralt 60 minuter f\u00f6re operation.<\/p>\n<p><strong>Administrering:<\/strong> ta med eller utan mat; kv\u00e4llsdoser \u00e4r st\u00f6rre \u00e4n dagdoser f\u00f6r att f\u00f6rskjuta sedering till s\u00f6mn. Undvik att hoppa \u00f6ver doser (risk f\u00f6r \u00e5terfall).<\/p>\n<p><strong>\u00d6vervakningsschema:<\/strong><\/p>\n<ul>\n<li><strong>Baslinje:<\/strong> blodtryck i liggande och st\u00e5ende position (dokumentera posturalt fall), hj\u00e4rtfrekvens, EKG (screening f\u00f6r bradykardi), l\u00e4kemedelslista (kontrollera interagerande preparat).<\/li>\n<li><strong>Vecka 1-2:<\/strong> upprepa blodtryck (liggande och st\u00e5ende), hj\u00e4rtfrekvens, symtombed\u00f6mning. Justera dos upp\u00e5t eller ned\u00e5t baserat p\u00e5 blodtryck och tolerabilitet.<\/li>\n<li><strong>Vecka 4-6:<\/strong> utv\u00e4rdera m\u00e5ltryck; symtomb\u00f6rda; fr\u00e5ga specifikt om missade doser.<\/li>\n<li><strong>P\u00e5g\u00e5ende:<\/strong> \u00e5rsvis blodtrycks- och hj\u00e4rtkontroll; f\u00f6rs\u00f6k aldrig f\u00e5 slut p\u00e5 medicin (risk f\u00f6r reboundhypertoni).<\/li>\n<li><strong>Avbryt eller minska dos vid:<\/strong> allvarlig bradykardi, syncope, andra eller tredjegrads AV-block, sv\u00e5r depression, besv\u00e4rlig sedering som inte f\u00f6rb\u00e4ttrats efter 4-8 veckor.<\/li>\n<\/ul>\n<p><strong>Avslutning:<\/strong> <strong>CRITICAL \u2014 never stop clonidine abruptly.<\/strong> Reboundhypertoni med en \u00f6kning av sympatisk aktivitet kan uppst\u00e5 inom 18-36 timmar vid doser &gt;300 mcg\/dag. <strong>Trappa ned \u00f6ver 2-4 veckor<\/strong>; om en betablockerare \u00e4r samtidigt ordinerad, avbryt betablockeraren f\u00f6rst och klonidin senare. S\u00f6k akut medicinsk v\u00e5rd vid allvarlig huvudv\u00e4rk, br\u00f6stsm\u00e4rta eller blodtryck &gt;180\/110 efter missade eller avbrutna doser.<\/p>\n<h2 class=\"wp-block-heading\">Praktiska \u00f6verv\u00e4ganden f\u00f6r Arkamin<\/h2>\n<ul>\n<li><strong>Rebound hypertension on abrupt discontinuation \u2014 CRITICAL, potentially life-threatening.<\/strong> Missade doser eller pl\u00f6tsligt avbrott kan orsaka en \u00f6kning av sympatisk aktivitet inom 18-36 timmar: blodtrycks\u00f6kning med 30-50 mmHg, takykardi, svettning, tremor och s\u00e4llsynta rapporter om stroke, hj\u00e4rtinfarkt och hypertensiv encefalopati. <strong>Trappa alltid ned klonidin \u00f6ver 2-4 veckor<\/strong> snarare \u00e4n att sluta abrupt. Riskerna \u00e4r st\u00f6rst vid doser &gt;300 mcg\/dag och i kombination med betablockerare.<\/li>\n<li><strong>Transdermal pl\u00e5ster<\/strong> (Catapres TTS, 100\/200\/300 mcg per day patches applied weekly) gives smoother plasma levels and mitigates rebound risk \u2014 useful for patients with adherence issues.<\/li>\n<li><strong>S\u00f6mnighet och torr mun<\/strong> \u00e4r n\u00e4stan universella vid behandlingsstart; brukar delvis avta \u00f6ver 2-4 veckor. Ta huvuddoseringen vid s\u00e4ngdags f\u00f6r att f\u00f6rl\u00e4gga s\u00f6mningen till sovtiden.<\/li>\n<li><strong>Varning f\u00f6r samtidig betablockerarebehandling<\/strong> \u2014 if discontinuing, stop the beta-blocker first, then taper clonidine several days later; reverse order can cause especially severe rebound because the beta-blocker blocks the compensatory reflexes.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Biverkningar<\/h2>\n<p><strong>Vanliga (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>S\u00f6mnighet, d\u00f6sighet<\/strong> (mycket vanligt, s\u00e4rskilt under de f\u00f6rsta 2-4 veckorna)<\/li>\n<li><strong>Torr mun<\/strong> (mycket vanligt)<\/li>\n<li><strong>Yrsel, ortostatisk hypotoni<\/strong><\/li>\n<li><strong>F\u00f6rstoppning<\/strong><\/li>\n<li><strong>Erektil dysfunktion och minskad libido<\/strong><\/li>\n<li><strong>Depression, hum\u00f6rf\u00f6r\u00e4ndringar<\/strong><\/li>\n<li><strong>Bradykardi, hj\u00e4rtblock<\/strong> (s\u00e4rskilt vid samtidig behandling med betablockerare eller digoxin)<\/li>\n<li><strong>Vikt\u00f6kning, saltretention<\/strong> \u00f6ver m\u00e5nader<\/li>\n<li><strong>Hudreaktioner vid transdermal pl\u00e5ster<\/strong> (kontaktdermatit 10-50%)<\/li>\n<li><strong>S\u00f6mnst\u00f6rningar, livliga dr\u00f6mmar, mardr\u00f6mmar<\/strong><\/li>\n<\/ul>\n<p><strong>Ovanligt men kliniskt betydelsefullt:<\/strong><\/p>\n<ul>\n<li><strong>Rebound-hypertensiv kris<\/strong> on abrupt discontinuation \u2014 stroke, MI, hypertensive encephalopathy reported.<\/li>\n<li><strong>Sv\u00e5r bradykardi och atrioventrikul\u00e4rt block<\/strong>, s\u00e4rskilt vid samtidig behandling med betablockerare, digoxin eller icke-dihydropyridinkalciumantagonister (verapamil, diltiazem).<\/li>\n<li><strong>Djup sedering<\/strong> interfering with work or driving \u2014 dose-limiting in some patients.<\/li>\n<li><strong>Depression<\/strong> eller f\u00f6rv\u00e4rring av tidigare depression.<\/li>\n<li><strong>Sinusnodsdysfunktion, synkope<\/strong>.<\/li>\n<li><strong>Sv\u00e5r allergisk kontaktdermatit vid anv\u00e4ndning av transdermal pl\u00e5ster<\/strong> \u2014 rotate sites; stop if severe.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikationer<\/h2>\n<ul>\n<li>K\u00e4nd \u00f6verk\u00e4nslighet mot klonidin<\/li>\n<li>Sv\u00e5r bradyarytmi, sjuk sinussyndrom, andra eller tredje gradens AV-block utan pacemaker<\/li>\n<li>Sv\u00e5r depression (relativ kontraindikation)<\/li>\n<li>Concurrent use of other central alpha-2 agonists (methyldopa, tizanidine) \u2014 additive hypotension and sedation<\/li>\n<li>Graviditet: undviks vanligtvis (f\u00f6redra metildopa eller labetalol); data \u00e4r begr\u00e4nsade, inte klart teratogena, men erfarenheten \u00e4r mycket st\u00f6rre med alternativen<\/li>\n<li>Amning: g\u00e5r \u00f6ver i br\u00f6stmj\u00f6lk i betydande m\u00e4ngder<\/li>\n<\/ul>\n<p><strong>Graviditet:<\/strong> generally avoided as first-choice \u2014 methyldopa and labetalol have larger safety databases. Clonidine is not clearly teratogenic and is sometimes used as add-on therapy in resistant gestational hypertension.<\/p>\n<p><strong>Amning:<\/strong> significant transfer to breast milk \u2014 monitor the infant for sedation, bradycardia, and poor feeding; consider alternative agents.<\/p>\n<h2 class=\"wp-block-heading\">L\u00e4kemedelsinteraktioner<\/h2>\n<ul>\n<li><strong>Beta-blockers \u2014 CRITICAL.<\/strong> Sambehandling f\u00f6rv\u00e4rrar klonidin-uppeh\u00e5llsreboundhypertoni. Om b\u00e5da l\u00e4kemedlen avbryts samtidigt, avbryt betablockeraren f\u00f6rst n\u00e5gra dagar, och trappa sedan ner klonidin. Betablockerare \u00f6kar ocks\u00e5 risken f\u00f6r bradykardi i kombination med klonidin.<\/li>\n<li><strong>Digoxin, icke-dihydropyridinkalciumblockerare (verapamil, diltiazem)<\/strong> \u2014 additive bradycardia and AV block.<\/li>\n<li><strong>Tricykliska antidepressiva och alfablockerare<\/strong> \u2014 partially antagonise clonidine\u2019s antihypertensive effect; may require higher clonidine doses.<\/li>\n<li><strong>CNS-depressiva (opioider, bensodiazepiner, alkohol, gabapentinoider)<\/strong> \u2014 additiv sedering.<\/li>\n<li><strong>Andra centralt verkande antihypertensiva (metyldopa, tizanidin, moxonidin)<\/strong> \u2014 additive sedation and hypotension; usually not combined.<\/li>\n<li><strong>Mirtazapin<\/strong> \u2014 alpha-2 antagonism reduces clonidine effect.<\/li>\n<li><strong>Diuretika<\/strong> \u2014 synergistic BP-lowering; standard combination in resistant HTN.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Var Arkamin passar in i antihypertensiv hierarki<\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 14px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Niv\u00e5<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Klass \/ Exempel<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Roll<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">F\u00f6rstahandsval<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">ACE-h\u00e4mmare (<a href=\"https:\/\/medsbase.com\/sv\/ramcor\/\">ramipril<\/a>), ARB (<a href=\"https:\/\/medsbase.com\/sv\/telmaheal\/\">telmisartan<\/a>), CCBs (<a href=\"https:\/\/medsbase.com\/sv\/amlode\/\">amlodipine<\/a>), tiazider (<a href=\"https:\/\/medsbase.com\/sv\/natrilix-sr\/\">indapamide<\/a>, HCTZ)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">B\u00f6rja h\u00e4r f\u00f6r nyuppt\u00e4ckt hypertoni<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Andra\/tredje preparat<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Kombinationer av ovanst\u00e5ende (ACE-h\u00e4mmare+CCB, ARB+tiazid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">N\u00e4r ett preparat inte r\u00e4cker<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fj\u00e4rde preparatet (resistent hypertoni)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/sv\/aldactone\/\">Spironolakton<\/a> (PATHWAY-2-bevis); betablockerare; doksazosin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Om blodtrycket inte kontrolleras med tre preparat i full dos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Femte preparat<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Alfablockerare<\/strong> (<a href=\"https:\/\/medsbase.com\/sv\/prazopress\/\">prazosin<\/a>, <a href=\"https:\/\/medsbase.com\/sv\/hytrin\/\">terazosin<\/a>, doxazosin); centralt verkande medel<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">L\u00e4gg till om spironolacton \u00e4r otillr\u00e4ckligt eller kontraindicerat; f\u00f6redra alfa-blockerare vid samtidig BPH<\/td>\n<\/tr>\n<tr style=\"background: #fff3cd;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Femte \/ sj\u00e4tte preparat<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Centralt verkande medel<\/strong> (<a href=\"https:\/\/medsbase.com\/sv\/arkamin\/\">klonidin<\/a>, moxonidin)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">L\u00e4gg till f\u00f6r att f\u00e5 resistent hypertoni till m\u00e5lv\u00e4rde; var uppm\u00e4rksam p\u00e5 rebound och sedering<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\">F\u00f6rsta val vid graviditet<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong><a href=\"https:\/\/medsbase.com\/sv\/alphadopa\/\">Metildopa<\/a><\/strong>, <a href=\"https:\/\/medsbase.com\/sv\/labebet\/\">labetalol<\/a>, nifedipin<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gestationshypertoni och tidigare hypertoni under graviditet<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">F\u00f6rvaring<\/h2>\n<p>Store Arkamin below 25\u00b0C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Vanliga fr\u00e5gor<\/h2>\n<h3 class=\"wp-block-heading\">Varf\u00f6r \u00e4r det s\u00e5 farligt att hoppa \u00f6ver doser av Arkamin?<\/h3>\n<p>Clonidine suppresses central sympathetic outflow. When clonidine levels fall abruptly, the stored sympathetic drive &#8220;rebounds&#8221; within 18-36 hours \u2014 BP surges 30-50 mmHg, heart rate rises, and the patient sweats, tremors, and develops severe headache. Case reports describe rebound stroke, myocardial infarction, and hypertensive encephalopathy. This risk is greatest at doses above 300 mcg\/day and with concurrent beta-blockade. <strong>Avbryt aldrig klonidin abrupt<\/strong> \u2014 taper over 2-4 weeks under medical supervision. Always order repeat supply 1-2 weeks before running out.<\/p>\n<h3 class=\"wp-block-heading\">Kommer Arkamin att g\u00f6ra mig s\u00f6mnig?<\/h3>\n<p>Yes \u2014 sedation and daytime somnolence are the most common complaints, affecting up to half of patients in the first 2-4 weeks. It usually improves substantially by week 4-6. Strategies: shift more of the daily dose to bedtime so sedation occurs during sleep; avoid alcohol and other CNS depressants; do not drive or operate machinery until you know how Arkamin affects you. If sedation remains unacceptable after 6-8 weeks, switch to an alternative (moxonidine, methyldopa in pregnancy only, or a different antihypertensive class).<\/p>\n<h3 class=\"wp-block-heading\">Kan jag ta Arkamin med alkohol?<\/h3>\n<p>Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension and sedation of Arkamin \u2014 falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.<\/p>\n<h3 class=\"wp-block-heading\">Kan Arkamin anv\u00e4ndas f\u00f6r ADHD?<\/h3>\n<p>Yes \u2014 clonidine is FDA-approved in the United States as extended-release <strong>Kapvay<\/strong> for ADHD in children and adolescents, and is used off-label (as immediate-release) internationally. It is not first-line (psychostimulants \u2014 methylphenidate, amphetamines \u2014 give larger mean effect sizes on core ADHD symptoms), but clonidine has a specific niche in hyperarousal, sleep onset, tics, and stimulant-side-effect management. Typical paediatric dose: 50-100 mcg at bedtime initially, titrating to 100-400 mcg\/day in divided doses under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Vad h\u00e4nder om jag missar en dos?<\/h3>\n<p><strong>Ta den missade dosen s\u00e5 snart du kommer ih\u00e5g det<\/strong>, even if it is close to the next scheduled dose \u2014 clonidine\u2019s rebound-hypertension risk means that missed doses must be replaced promptly. If you realise within 6 hours, take the missed dose and continue as normal. If more than 12 hours have passed and rebound symptoms (severe headache, palpitations, sweating) are emerging, take the dose and seek urgent medical review. Never let your supply run out \u2014 order repeat prescriptions 1-2 weeks before the current stock is exhausted.<\/p>\n<h3 class=\"wp-block-heading\">Kan jag sluta med Arkamin om mitt blodtryck \u00e4r under kontroll?<\/h3>\n<p><strong>Inte abrupt.<\/strong> Rebound-hypertension inom 18-36 timmar efter att ha slutat med klonidin kan leda till stroke, hj\u00e4rtinfarkt eller hypertensiv encefalopati. Trappa alltid av under 2-4 veckor under medicinsk \u00f6vervakning. Om du tar en betablockerare, sluta med betablockeraren f\u00f6rst och trappa sedan av klonidin n\u00e5gra dagar senare.<\/p>\n<h3 class=\"wp-block-heading\">Kan jag ta Arkamin under graviditet?<\/h3>\n<p>Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine \u2014 Arkamin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.<\/p>\n<h3 class=\"wp-block-heading\">Var kan jag k\u00f6pa Arkamin online?<\/h3>\n<p>Du kan k\u00f6pa Arkamin (100 mcg klonidin, 30-90 tabletter) fr\u00e5n MedsBase med diskret f\u00f6rpackning och v\u00e4rldsomsp\u00e4nnande leverans.<\/p>\n<h2 class=\"wp-block-heading\">Relaterade blodtryckss\u00e4nkande medel p\u00e5 MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/aldactone\/\">Aldactone \u2014 Spironolactone 25\/50\/100 mg (PATHWAY-2 4th-line)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/alphadopa\/\">Alphadopa \u2014 Methyldopa 250 mg (pregnancy-safe HTN)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/hytrin\/\">Hytrin \u2014 Terazosin 1\/2\/5 mg (AbbVie)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/minipress-xl\/\">Minipress XL \u2014 Prazosin ER 2.5\/5 mg (Pfizer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/ramcor\/\">Ramcor \u2014 Ramipril 2.5\/5\/10 mg (ACEi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/telma-h\/\">Telma H \u2014 Telmisartan + HCTZ combination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/high-blood-pressure-medication\/\"><strong>Bl\u00e4ddra bland alla blodtryckss\u00e4nkande l\u00e4kemedel<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background: #fff3f3; border-left: 4px solid #d9534f; padding: 16px 20px; margin: 24px 0; border-radius: 4px;\"><strong>\u2695 Medical Disclaimer.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor \u2014 always use beta-blockers under medical guidance.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterade alternativ<\/h3>\n<p>Andra produkter inom <strong>Kroniska tillst\u00e5nd<\/strong> som kunder \u00e4ven tittar p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/robinax\/\">Robinax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/affexor-xr\/\">Affexor XR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/xyzal\/\">Xyzal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/duolin-inhaler\/\">Duolin Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/noltrexate\/\">Noltrexate<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Arkamin \u00e4r Torrent Pharmas clonidine 100 mcg-tabletter \u2014 den ursprungliga centralt verkande alfa-2-adrenerga agonisten (Boehringer Ingelheims Catapres, 1966). Minskar den centrala sympatiska utfl\u00f6det; s\u00e4nker perifer noradrenalin med 30-50%. Anv\u00e4ndningsomr\u00e5den: fj\u00e4rde\/femte-linjens hypertoni, hypertensiv akutsituation, ADHD (FDA-godk\u00e4nd som Kapvay XR i USA), opiat- och nikotinabstinens, menopausala v\u00e5ldsamma svettningar, Tourettes syndrom, anestesibihj\u00e4lpmedel. KRITISKT \u2014 avbryt aldrig abrupt (\u00e5terfallshypertoni med risk f\u00f6r stroke, hj\u00e4rtinfarkt).<\/p>","protected":false},"featured_media":51443,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3357,3358],"class_list":{"0":"post-51442","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arkamin","11":"product_tag-clonidine","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/51442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=51442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/51443"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=51442"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=51442"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=51442"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=51442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}